Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan-Feb;38(1):271-275.
doi: 10.12669/pjms.38.1.4609.

Clinical application of compound Glycyrrhizin tablets in the treatment of patients with Simplex Henoch-Schonlein Purpura and its effect on immune function

Chao Li  1 , Zhi-Bin Wang  2
Affiliations

Clinical application of compound Glycyrrhizin tablets in the treatment of patients with Simplex Henoch-Schonlein Purpura and its effect on immune function

Chao Li et al. Pak J Med Sci. 2022 Jan-Feb.

Abstract

Objectives: To investigate the curative effect of Compound Glycyrrhizin Tablets in the adjuvant treatment of simplex Henoch-Schonlein purpura and its influence in improving immune function.

Methods: In this retrospective study design was used in this study. Eighty newly diagnosed patients with purpura simplex who visited the outpatient department of Baoding First Central Hospital from June 2017 to February 2020 were included. They were randomly divided into treatment group and control group. The two groups were provided with the same conventional comprehensive treatment. Patients in the treatment group received oral administration of Compound Glycyrrhizin Tablets on the basis of conventional treatment. The clinical efficacy of the treatment group and the control group were compared according to the time and effect of purpura regression, followed by the comparison of changes of T cell subsets before and after treatment.

Results: The total effective rate of the treatment group was 92.5%, which was higher than that of the control group (77.5%) (P < 0.05). The purpura subsidence time of effective patients in treatment group was shorter than that in control group (P < 0.05). There was no significant difference in lymphocyte subsets between the treatment group and the control group before treatment. After treatment, the proportion of CD4+ cells and CD4+/CD8+ cells in the treatment group were obviously higher than that in the control group, and the count of CD8+ cells was evidently lower than that in the control group (P < 0.05).

Conclusions: Compound Glycyrrhizin is effective in the adjuvant treatment of simplex Henoch-Schonlein purpura without obvious adverse reactions, which is valuable for clinical application as an adjuvant.

Keywords: Compound Glycyrrhizin; Henoch-Schonlein purpura; Lymphocyte subsets.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

References

    1. Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schönlein Purpura:A Literature Review. Acta Derm Venereol. 2017;97(10):1160–1166. doi:10.2340/00015555-2733. - PubMed
    1. Roache-Robinson P, Hotwagner DT. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing;2021 Jan–; 2020. Dec 2, Henoch Schönlein Purpura. - PubMed
    1. Di Pietro GM, Castellazzi ML, Mastrangelo A, Montini G, Marchisio P, Tagliabue C. Henoch-Schönlein Purpura in children:not only kidney but also lung. Pediatr Rheumatol Online J. 2019;17(1):75. doi:10.1186/s12969-019-0381-y. - PMC - PubMed
    1. Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC, Van Egmond M. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura) Autoimmun Rev. 2017;16(12):1246–1253. doi:10.1016/j.autrev.2017.10.009. - PubMed
    1. Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, et al. Henoch-Schönlein purpura nephritis in childhood:pathogenesis, prognostic factors and treatment. Fukushima J Med Sci. 2013;59(1):15–26. doi:10.5387/fms.59.15. - PubMed

LinkOut - more resources